Transcutaneous Electrical Nerve Stimulation Market Size, Share & Trends Analysis By Product Type (Portable, Table Top), By Application (Chronic Pain, Acute Pain), By End-use (Hospitals, Physiotherapy Clinics), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Transcutaneous Electrical Nerve Stimulation Market Growth & Trends
The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to expand at a CAGR of 3.84% from 2022 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.
Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.
The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.
Transcutaneous Electrical Nerve Simulation Market Report Highlights
Transcutaneous Electrical Nerve Stimulation Market Growth & Trends
The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to expand at a CAGR of 3.84% from 2022 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.
Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.
The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.
Transcutaneous Electrical Nerve Simulation Market Report Highlights
- Based on product type, the portable segment dominated the market with a revenue share of 71.70% in 2021 and is anticipated to witness the highest CAGR of 4.0% during the forecast period. Portable TENS would decrease the number of doctor visits for patients, therefore are anticipated to support market growth over the forecast period.
- Based on application, the chronic pain segment is likely to witness the fastest growth in the forecast period, owing to the growing prevalence of chronic pain, especially amongst senior citizens.
- Based on end-use, physiotherapy clinics dominated the market. The growing preference of physiotherapists toward electrotherapy as compared to manual techniques is a major factor driving the growth of this segment.
- On the other hand, the home healthcare segment is anticipated to witness the fastest growth of a CAGR of 4.9% over the forecast period.
- North America dominated the market with the highest revenue share of 43.91% in 2021 owing to the presence of key participants, and the high purchasing power of consumers.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation And Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 PRIMARY Research
1.3.5 Details OF Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Vplume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Cases Of Chronic And Acute Pain
3.5.1.2 Ineffectiveness Of Oral Drugs And Low Preference For Surgical Intervention
3.5.1.3 Rising Geriatric Population
3.5.1.4 Rising Demand For Reduced Hospital Stay
3.5.1.5 Increasing Number Of Surgeries
3.5.1.6 Rising Cases Of Anterior Cruciate Ligament (Acl) Tear, Hip Flexor Strain, And Hamstring Strain Among Sports Players
3.5.2 Market Restraints Analysis
3.5.2.1 Adverse Effects Associated With Devices
3.5.2.2 Increased Cost Of Nerve Stimulation Therapy
3.6 Transcutaneous Electrical Nerve Stimulation: Market Analysis Tools
3.6.1 Industry Analysis - PORTER’S
3.6.2 SWOT Analysis, By PEST
3.7 Impact Of COVID-19 On Market
CHAPTER 4 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY PRODUCT TYPE, 2017 - 2030 (USD MILLION)
4.1 Definition And Scope
4.2 Product Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Product Type Type, 2017 To 2030
4.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
4.5.1 Portables Tens
4.5.1.1 Portable Tens Market, 2017 - 2030 (USD Million)
4.5.2 Table Top Tens
4.5.2.1 Table Top Tens Market, 2017 - 2030 (USD Million)
CHAPTER 5 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY APPLICATION, 2017 - 2030 (USD MILLION)
5.1 Definition And Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2017 To 2030
5.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
5.5.1 Chronic Pain
5.5.1.1 Chronic Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.1 Arthritis Market, 2017 - 2030 (USD Million)
5.5.1.1.2 Back & Neck Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.3 Fibromyalgia Market, 2017 - 2030 (USD Million)
5.5.1.1.4 Neuropathic Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.5 Others Market, 2017 - 2030 (USD Million)
5.5.2 Acute Pain
5.5.2.1 Acute Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.1 Sports Injuries Market, 2017 - 2030 (USD Million)
5.5.2.1.2 Postoperative Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.3 Labor Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.4 Menstrual Pain Market, 2017 - 2030 (USD Million)
CHAPTER 6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY END-USE, 2017 - 2030 (USD MILLION)
6.1 Definition And Scope
6.2 End-Use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Transcutaneous Electrical Nerve Stimulation Market, By End-Use, 2017 To 2030
6.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
6.5.1 Hospitals
6.5.1.1 Hospitals Market, 2017 - 2030 (USD Million)
6.5.2 Physiotherapy Clinics
6.5.2.1 Physiotherapy Clinics Market, 2017 - 2030 (USD Million)
6.5.3 Rehabilitation Centers
6.5.3.1 Rehabilitation Centers Market, 2017 - 2030 (USD Million)
6.5.4 Home Care
6.5.4.1 Home Care Market, 2017 - 2030 (USD Million)
6.5.5 Others
6.5.5.1 Others Market, 2017 - 2030 (USD Million)
CHAPTER 7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: REGIONAL MARKET ANALYSIS, BY PRODUCT TYPE, BY APPLICATION, BY END-USE 2017 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, And Trend Analysis, 2020 To 2028
7.6 North America
7.6.1 North America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.6.2 U.S.
7.6.2.1 U.S. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.6.3 Canada
7.6.3.1 Canada Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7 Europe
7.7.1 Europe Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.2 U.K.
7.7.2.1 U.K. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.3 Germany
7.7.3.1 Germany Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.4 France
7.7.4.1 France Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.5 Italy
7.7.5.1 Italy Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.6 Spain
7.7.6.1 Spain Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8 Asia Pacific
7.8.1 Asia Pacific Transcutaneous Electrical Nerve StimulationMarket, 2017 - 2030 (USD Million)
7.8.2 Japan
7.8.2.1 Japan Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.3 China
7.8.3.1 China (Mainland) Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.4 India
7.8.4.1 India Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.5 South Korea
7.8.5.1 South Korea Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.6 Australia
7.8.6.1 Australia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9 Latin America
7.9.1 Latin America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.2 Brazil
7.9.2.1 Brazil Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.3 Mexico
7.9.3.1 Mexico Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.4 Argentina
7.9.4.1 Argentina Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.5 Colombia
7.9.5.1 Colombia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10 MEA
7.10.1 MEA Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.2 South Africa
7.10.2.1 South Africa Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.3 Saudi Arabia
7.10.3.1 Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.4 Saudi Arabia
7.10.4.1 UAE Market, 2017 - 2030 (USD Million)
CHAPTER 8 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET - COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Company Profiles
8.3.1 OMRON CORPORATION
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 ZYNEX MEDICAL
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 NEUROMETRIX, INC.
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 EMS PHYSIO LTD.
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 BIOMEDICAL LIFE SYSTEMS
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 DJO GLOBAL, INC.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 GLOBUS
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
1.1 Market Segmentation And Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 PRIMARY Research
1.3.5 Details OF Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Vplume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Cases Of Chronic And Acute Pain
3.5.1.2 Ineffectiveness Of Oral Drugs And Low Preference For Surgical Intervention
3.5.1.3 Rising Geriatric Population
3.5.1.4 Rising Demand For Reduced Hospital Stay
3.5.1.5 Increasing Number Of Surgeries
3.5.1.6 Rising Cases Of Anterior Cruciate Ligament (Acl) Tear, Hip Flexor Strain, And Hamstring Strain Among Sports Players
3.5.2 Market Restraints Analysis
3.5.2.1 Adverse Effects Associated With Devices
3.5.2.2 Increased Cost Of Nerve Stimulation Therapy
3.6 Transcutaneous Electrical Nerve Stimulation: Market Analysis Tools
3.6.1 Industry Analysis - PORTER’S
3.6.2 SWOT Analysis, By PEST
3.7 Impact Of COVID-19 On Market
CHAPTER 4 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY PRODUCT TYPE, 2017 - 2030 (USD MILLION)
4.1 Definition And Scope
4.2 Product Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Product Type Type, 2017 To 2030
4.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
4.5.1 Portables Tens
4.5.1.1 Portable Tens Market, 2017 - 2030 (USD Million)
4.5.2 Table Top Tens
4.5.2.1 Table Top Tens Market, 2017 - 2030 (USD Million)
CHAPTER 5 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY APPLICATION, 2017 - 2030 (USD MILLION)
5.1 Definition And Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2017 To 2030
5.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
5.5.1 Chronic Pain
5.5.1.1 Chronic Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.1 Arthritis Market, 2017 - 2030 (USD Million)
5.5.1.1.2 Back & Neck Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.3 Fibromyalgia Market, 2017 - 2030 (USD Million)
5.5.1.1.4 Neuropathic Pain Market, 2017 - 2030 (USD Million)
5.5.1.1.5 Others Market, 2017 - 2030 (USD Million)
5.5.2 Acute Pain
5.5.2.1 Acute Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.1 Sports Injuries Market, 2017 - 2030 (USD Million)
5.5.2.1.2 Postoperative Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.3 Labor Pain Market, 2017 - 2030 (USD Million)
5.5.2.1.4 Menstrual Pain Market, 2017 - 2030 (USD Million)
CHAPTER 6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: SEGMENT ANALYSIS, BY END-USE, 2017 - 2030 (USD MILLION)
6.1 Definition And Scope
6.2 End-Use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Transcutaneous Electrical Nerve Stimulation Market, By End-Use, 2017 To 2030
6.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
6.5.1 Hospitals
6.5.1.1 Hospitals Market, 2017 - 2030 (USD Million)
6.5.2 Physiotherapy Clinics
6.5.2.1 Physiotherapy Clinics Market, 2017 - 2030 (USD Million)
6.5.3 Rehabilitation Centers
6.5.3.1 Rehabilitation Centers Market, 2017 - 2030 (USD Million)
6.5.4 Home Care
6.5.4.1 Home Care Market, 2017 - 2030 (USD Million)
6.5.5 Others
6.5.5.1 Others Market, 2017 - 2030 (USD Million)
CHAPTER 7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET: REGIONAL MARKET ANALYSIS, BY PRODUCT TYPE, BY APPLICATION, BY END-USE 2017 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, And Trend Analysis, 2020 To 2028
7.6 North America
7.6.1 North America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.6.2 U.S.
7.6.2.1 U.S. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.6.3 Canada
7.6.3.1 Canada Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7 Europe
7.7.1 Europe Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.2 U.K.
7.7.2.1 U.K. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.3 Germany
7.7.3.1 Germany Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.4 France
7.7.4.1 France Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.5 Italy
7.7.5.1 Italy Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.7.6 Spain
7.7.6.1 Spain Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8 Asia Pacific
7.8.1 Asia Pacific Transcutaneous Electrical Nerve StimulationMarket, 2017 - 2030 (USD Million)
7.8.2 Japan
7.8.2.1 Japan Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.3 China
7.8.3.1 China (Mainland) Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.4 India
7.8.4.1 India Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.5 South Korea
7.8.5.1 South Korea Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.8.6 Australia
7.8.6.1 Australia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9 Latin America
7.9.1 Latin America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.2 Brazil
7.9.2.1 Brazil Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.3 Mexico
7.9.3.1 Mexico Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.4 Argentina
7.9.4.1 Argentina Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.9.5 Colombia
7.9.5.1 Colombia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10 MEA
7.10.1 MEA Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.2 South Africa
7.10.2.1 South Africa Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.3 Saudi Arabia
7.10.3.1 Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
7.10.4 Saudi Arabia
7.10.4.1 UAE Market, 2017 - 2030 (USD Million)
CHAPTER 8 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) MARKET - COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Company Profiles
8.3.1 OMRON CORPORATION
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 ZYNEX MEDICAL
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 NEUROMETRIX, INC.
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 EMS PHYSIO LTD.
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 BIOMEDICAL LIFE SYSTEMS
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 DJO GLOBAL, INC.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 GLOBUS
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
LIST OF TABLES
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 4. North America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 5. North America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 6. North America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 7. U.S. transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 8. U.S. transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 9. U.S. transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 10. Canada transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 11. Canada transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 12. Canada transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 13. Europe transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 14. Europe transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 15. Europe transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 16. Europe transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 17. UK transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 18. UK transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 19. UK transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 20. Germany transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 21. Germany transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 22. Germany transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 23. France transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 24. France transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 25. France transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 26. Italy transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 27. Italy transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 28. Italy transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 29. Spain transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 30. Spain transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 31. Spain transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 32. Asia Pacific transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 33. Asia Pacific transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 34. Asia Pacific transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 35. Asia Pacific transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 36. China transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 37. China transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 38. China transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 39. Japan transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 40. Japan transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 41. Japan transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 42. India transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 43. India transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 44. India transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 45. South Korea transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 46. South Korea transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 47. South Korea transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 48. Australia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 49. Australia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 50. Australia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 51. Latin America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 52. Latin America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 53. Latin America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 54. Latin America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 55. Brazil transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 56. Brazil transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 57. Brazil transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 58. Mexico transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 59. Mexico transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 60. Mexico transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 61. Argentina transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 62. Argentina transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 63. Argentina transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 64. Colombia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 65. Colombia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 66. Colombia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 67. Middle East & Africa transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 68. Middle East & Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 69. Middle East & Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 70. Middle East & Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 71. South Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 72. South Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 73. South Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 74. Saudi Arabia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 75. Saudi Arabia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 76. Saudi Arabia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 77. UAE transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 78. UAE transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 79. UAE transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 4. North America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 5. North America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 6. North America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 7. U.S. transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 8. U.S. transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 9. U.S. transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 10. Canada transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 11. Canada transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 12. Canada transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 13. Europe transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 14. Europe transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 15. Europe transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 16. Europe transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 17. UK transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 18. UK transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 19. UK transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 20. Germany transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 21. Germany transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 22. Germany transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 23. France transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 24. France transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 25. France transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 26. Italy transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 27. Italy transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 28. Italy transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 29. Spain transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 30. Spain transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 31. Spain transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 32. Asia Pacific transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 33. Asia Pacific transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 34. Asia Pacific transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 35. Asia Pacific transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 36. China transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 37. China transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 38. China transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 39. Japan transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 40. Japan transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 41. Japan transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 42. India transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 43. India transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 44. India transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 45. South Korea transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 46. South Korea transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 47. South Korea transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 48. Australia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 49. Australia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 50. Australia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 51. Latin America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 52. Latin America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 53. Latin America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 54. Latin America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 55. Brazil transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 56. Brazil transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 57. Brazil transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 58. Mexico transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 59. Mexico transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 60. Mexico transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 61. Argentina transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 62. Argentina transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 63. Argentina transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 64. Colombia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 65. Colombia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 66. Colombia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 67. Middle East & Africa transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
Table 68. Middle East & Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 69. Middle East & Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 70. Middle East & Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 71. South Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 72. South Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 73. South Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 74. Saudi Arabia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 75. Saudi Arabia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 76. Saudi Arabia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
Table 77. UAE transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
Table 78. UAE transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
Table 79. UAE transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Transcutaneous electrical nerve stimulation market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7. QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Transcutaneous electrical nerve stimulation market: Product type movement analysis
Fig. 19 Segment dashboard
Fig. 20 Transcutaneous electrical nerve stimulation market product type outlook: Key takeaways
Fig. 21 Portable TENS market, 2017 - 2030 (USD Million)
Fig. 22 Tabletop TENS market, 2017 - 2030 (USD Million)
Fig. 23 Transcutaneous electrical nerve stimulation market: Application movement analysis
Fig. 24 Segment dashboard
Fig. 25 Transcutaneous electrical nerve stimulation market Application outlook: Key takeaways
Fig. 26 Chronic pain market, 2017 - 2030 (USD Million)
Fig. 27 Arthritis market, 2017 - 2030 (USD Million)
Fig. 28 Fibromyalgia market, 2017 - 2030 (USD Million)
Fig. 29 Neuropathic Pain market, 2017 - 2030 (USD Million)
Fig. 30 Others market, 2017 - 2030 (USD Million)
Fig. 31 Acute pain market, 2017 - 2030 (USD Million)
Fig. 32 Sports injuries market, 2017 - 2030 (USD Million)
Fig. 33 Postoperative pain market, 2017 - 2030 (USD Million)
Fig. 34 Labor pain market, 2017 - 2030 (USD Million)
Fig. 35 Menstrual pain market, 2017 - 2030 (USD Million)
Fig. 36 Transcutaneous electrical nerve stimulation market: End-use movement analysis
Fig. 37 Segment dashboard
Fig. 38 Transcutaneous electrical nerve stimulation market end-use outlook: Key takeaways
Fig. 39 Hospital market, 2017 - 2030 (USD Million)
Fig. 40 Physiotherapy clinics market, 2018 -- 2030 (USD Million)
Fig. 41 Rehabilitation centers market, 2017 - 2030 (USD Million)
Fig. 42 Home care market, 2017 - 2030 (USD Million)
Fig. 43 Others market, 2017 - 2030 (USD Million)
Fig. 44 Regional outlook, 2021 & 2030
Fig. 45 Regional market dashboard
Fig. 46 Regional market place: Key takeaways
Fig. 47 North America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 48 U.S transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 49 Canada transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 50 Europe transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 51 UK transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 52 Germany transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 53 France transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 54 Italy transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 55 Netherlands transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 56 Spain transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 57 Sweden transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 58 Asia Pacific transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 59 Japan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 60 China transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 61 India transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 62 South Korea transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 63 Taiwan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 64 Australia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 65 Vietnam transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 66 Latin America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 67 Brazil transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 68 Mexico transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 69 MEA transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 70 South Africa transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 71 Saudi Arabia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 72 Company market share analysis, 2021
Fig. 73 Market differentiators
Fig. 74. Regional network map
Fig. 1 Transcutaneous electrical nerve stimulation market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7. QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Transcutaneous electrical nerve stimulation market: Product type movement analysis
Fig. 19 Segment dashboard
Fig. 20 Transcutaneous electrical nerve stimulation market product type outlook: Key takeaways
Fig. 21 Portable TENS market, 2017 - 2030 (USD Million)
Fig. 22 Tabletop TENS market, 2017 - 2030 (USD Million)
Fig. 23 Transcutaneous electrical nerve stimulation market: Application movement analysis
Fig. 24 Segment dashboard
Fig. 25 Transcutaneous electrical nerve stimulation market Application outlook: Key takeaways
Fig. 26 Chronic pain market, 2017 - 2030 (USD Million)
Fig. 27 Arthritis market, 2017 - 2030 (USD Million)
Fig. 28 Fibromyalgia market, 2017 - 2030 (USD Million)
Fig. 29 Neuropathic Pain market, 2017 - 2030 (USD Million)
Fig. 30 Others market, 2017 - 2030 (USD Million)
Fig. 31 Acute pain market, 2017 - 2030 (USD Million)
Fig. 32 Sports injuries market, 2017 - 2030 (USD Million)
Fig. 33 Postoperative pain market, 2017 - 2030 (USD Million)
Fig. 34 Labor pain market, 2017 - 2030 (USD Million)
Fig. 35 Menstrual pain market, 2017 - 2030 (USD Million)
Fig. 36 Transcutaneous electrical nerve stimulation market: End-use movement analysis
Fig. 37 Segment dashboard
Fig. 38 Transcutaneous electrical nerve stimulation market end-use outlook: Key takeaways
Fig. 39 Hospital market, 2017 - 2030 (USD Million)
Fig. 40 Physiotherapy clinics market, 2018 -- 2030 (USD Million)
Fig. 41 Rehabilitation centers market, 2017 - 2030 (USD Million)
Fig. 42 Home care market, 2017 - 2030 (USD Million)
Fig. 43 Others market, 2017 - 2030 (USD Million)
Fig. 44 Regional outlook, 2021 & 2030
Fig. 45 Regional market dashboard
Fig. 46 Regional market place: Key takeaways
Fig. 47 North America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 48 U.S transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 49 Canada transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 50 Europe transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 51 UK transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 52 Germany transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 53 France transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 54 Italy transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 55 Netherlands transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 56 Spain transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 57 Sweden transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 58 Asia Pacific transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 59 Japan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 60 China transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 61 India transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 62 South Korea transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 63 Taiwan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 64 Australia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 65 Vietnam transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 66 Latin America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 67 Brazil transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 68 Mexico transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 69 MEA transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 70 South Africa transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 71 Saudi Arabia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
Fig. 72 Company market share analysis, 2021
Fig. 73 Market differentiators
Fig. 74. Regional network map
